Delhi HC blocks Reliance from launching copy of Roche's breast cancer drug
Delhi High Court has blocked Reliance Life Sciences from launching copies of Swiss drug maker Roche’s breast cancer drug trastuzmab, branded as Herceptin.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Herceptin | Legislation | Pharmaceuticals